ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

INTI Inhibitor Therapeutics Inc (QB)

0.13
0.00 (0.00%)
May 08 2024 - Closed
Delayed by 15 minutes

Inhibitor Therapeutics (QB) Financial Summary

The current INTI market cap is 22.36M. The company's latest EPS is USD -0.0176 and P/E is -7.39.

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -2.75M-1.06M-325k-658k-3.41M
Net Income -2.93M-1.26M-499k11.92M-3.03M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 900k132k59k11.98M8.95M
Total Liabilities 3.43M3.49M3.68M3.68M3.67M
Total Equity -2.53M-7.32M-3.62M8.3M5.28M

Cash Flow

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -2.71M-825k-220k11.74M-2.7M
Investing N/A N/A N/A N/A N/A
Financing 2.4M96k176k180k-411k
Market Cap 22.36M
Price to Earnings Ratio -7.39
Price to Sales Ratio 0
Price to Cash Ratio 2.53
Price to Book Ratio 4.23
Dividend Yield -

Share Statistics

Shares Outstanding 172.02M
Average Volume (1 week) 12.48k
Average Volume (1 Month) 7.71k
52 Week Change 356.14%
52 Week High 0.2999
52 Week Low 0.0131
Spread (Intraday) 0.06 (41.42%)

Company Info

Company Name Inhibitor Therapeutics Inc (QB)
Address 108 w. 13th street suite 100
wilmington, delaware 19801
Website https://inhibitortx.com
Industry coml physical, biologcl resh (8731)

Your Recent History

Delayed Upgrade Clock